Provocative techniques should not be used for the diagnosis of psychogenic nonepileptic seizures

Epilepsy and Behavior

Volumn 15, Issue 2, 2009, Pages 110-114

  Leeman, Beth A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; PLACEBO; SEDATIVE AGENT;

ANXIETY; APLASTIC ANEMIA; ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; DOCTOR PATIENT RELATION; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FALSE POSITIVE RESULT; HUMAN; INFORMED CONSENT; MEDICAL CARE; MEDICAL ETHICS; MENTAL DISEASE; MORALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT CARE PLANNING; PATIENT SAFETY; PERSONALITY DISORDER; PROVOCATION TEST; SEIZURE; SENSITIVITY AND SPECIFICITY; STEVENS JOHNSON SYNDROME; SUICIDE;

DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; PSYCHOPHYSIOLOGIC DISORDERS;

EID: 67349128632     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.01.013     Document Type: Article

References (47)

1. Gumnit R.J. The differential diagnosis of epilepsy in nonepileptic paroxysmal disorders. In: Wyllie E. (Ed). The treatment of epilepsy: principles and practices (1993), Lea & Febiger, Philadelphia 692-696
2. Massey E.W., and McHenry L.C. Hysteroepilepsy in the nineteenth century: Charcot and Gowers. Neurology 36 (1986) 65-67
3. Goetz C.G. J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies. Neurology 69 (2007) 103-109
4. LaFrance W.C., and Devinsky O. The treatment of nonepileptic seizures: historical perspectives and future directions. Epilepsia 45 Suppl. 2 (2004) 15-21
5. Tucker B.R. Speaking of Weir Mitchell. Am J Psychiatry 93 (1936) 341-346
6. Levy R.S., and Jankovic J. Placebo-induced conversion reaction: a neurobehavioral and EEG study of hysterical aphasia, seizure, and coma. J Abnorm Psychol 92 (1983) 243-249
7. Monday K., and Jankovic J. Psychogenic myoclonus. Neurology 43 (1993) 349-352
8. Fahn S., and Williams D.T. Psychogenic dystonia. Adv Neurol 50 (1988) 431-455
9. Platt R. Two essays on the practice of medicine. Lancet 250 (1947) 305-307
10. Sieber J.E., Iannuzzo R., and Rodriguez B. Deception methods in psychology: have they changed in 23 years?. Ethics Behav 5 (1995) 67-85
11. Schachter S.C., Brown F., and Rowan A.J. Provocative testing for nonepileptic seizures: attitudes and practices in the United States among American Epilepsy Society members. J Epilepsy 9 (1996) 249-252
12. Stagno S.J., and Smith M.L. Use of induction procedures in diagnosing psychogenic seizures. J Epilepsy 9 (1996) 153-158
13. Burack J.H., Back A.L., and Pearlman R.A. Provoking nonepileptic seizures: the ethics of deceptive diagnostic testing. Hastings Cent Rep 27 (1997) 24-33
14. Ribaï P., Tugendhaft P., and Legros B. Usefulness of prolonged video-EEG monitoring and provocative procedure with saline injection for the diagnosis of non epileptic seizures of psychogenic origin. J Neurol 253 (2006) 328-332
15. Howe E.G. Deceiving patients for their own good. J Clin Ethics 8 (1997) 211-216
16. Drake Jr. M.E. Saline activation of pseudoepileptic seizures: clinical EEG and neuropsychiatric observations. Clin Electroencephalogr 16 (1985) 171-176
17. Smith M.L., Stagno S.J., Dolske M., et al. Induction procedures for psychogenic seizures: ethical and clinical considerations. J Clin Ethics 8 (1997) 217-229
18. Stagno S.J., and Smith M.L. The use of placebo in diagnosing psychogenic seizures: who is being deceived?. Semin Neurol 17 (1997) 213-218
19. Kirk E.P. Treatment by deception is bad medicine. Lancet 362 (2003) 668
20. Cohen R.J., and Suter C. Hysterical seizures: suggestion as a provocative EEG test. Ann Neurol 11 (1982) 391-395
21. Dericioǧlu N., Saygi S., and Ciǧer A. The value of provocation methods in patients suspected of having non-epileptic seizures. Seizure 8 (1999) 152-156
22. Lancman M.E., Asconape J.J., Craven W.T., Howard G., and Penry J.K. Predictive value of induction of psychogenic seizures by suggestion. Ann Neurol 35 (1994) 359-361
23. Walczak T.S., Williams D.T., and Berten W. Utility and reliability of placebo infusion in the evaluation of patients with seizures. Neurology 44 (1994) 394-399
24. Bazil C.W., Kothari M., Luciano D., et al. Provocation of nonepileptic seizures by suggestion in a general seizure population. Epilepsia 35 (1994) 768-770
25. Zaidi A., Crampton S., Clough P., Fitzpatrick A., and Scheepers B. Head-up tilting is a useful provocative test for psychogenic non-epileptic seizures. Seizure 8 (1999) 353-355
26. O'Sullivan S.S., Spillane J.E., McMahon E.M., et al. Clinical characteristics and outcome of patients diagnosed with psychogenic nonepileptic seizures: a 5-year review. Epilepsy Behav 11 (2007) 77-84
27. Kotagal P., Costa M., Wyllie E., and Wolgamuth B. Paroxysmal nonepileptic events in children and adolescents. Pediatrics 110 (2002) e46
28. Benbadis S.R., Agrawal V., and Tatum W.O. How many patients with psychogenic nonepileptic seizures also have epilepsy?. Neurology 57 (2001) 915-917
29. Ozkara C., and Dreifuss F.E. Differential diagnosis in pseudoepileptic seizures. Epilepsia 34 (1993) 294-298
30. Meierkord H., Will B., Fish D., and Shorvon S. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology 41 (1991) 1643-1646
31. Reuber M., Fernandez G., Bauer J., Helmstaedter C., and Elger C.E. Diagnostic delay in psychogenic nonepileptic seizures. Neurology 58 (2002) 493-495
32. Schachter SC. Psychiatric disorders that resemble seizures. In: Fisch B, editor. Epilepsy and intensive care monitoring: principles and practice. New York: Demos Medical Publishing; in press.
33. Devinsky O., and Fisher R. Ethical use of placebos and provocative testing in diagnosing nonepileptic seizures. Neurology 47 (1996) 866-870
34. Benbadis S.R., Johnson K., Anthony K., et al. Induction of psychogenic nonepileptic seizures without placebo. Neurology 55 (2000) 1904-1905
35. Benbadis S.R., Siegrist K., Tatum W.O., Heriaud L., and Anthony K. Short-term outpatient EEG video with induction in the diagnosis of psychogenic seizures. Neurology 63 (2004) 1728-1730
36. Park L.C., and Covi L. Nonblind placebo trial: an exploration of neurotic outpatients' response to placebo when its inert content is disclosed. Arch Gen Psychiatry 12 (1965) 336-345
37. Vogel A.V., Goodwin J.S., and Goodwin J.M. The therapeutics of placebo. Am Fam Physician 22 (1980) 105-109
38. Brody H. The lie that heals: the ethics of giving placebos. Ann Intern Med 97 (1982) 112-118
39. Parra J., Kanner A.M., Iriarte J., and Gil-Nagel A. When should induction protocols be used in the diagnostic evaluation of patients with paroxysmal events?. Epilepsia 39 (1998) 863-867
40. Evans M. Justified deception? The single blind placebo in drug research. J Med Ethics 26 (2000) 188-193
41. Dowrick C.F., Hughes J.G., Hiscock J.J., Wigglesworth M., and Walley T.J. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants. BMC Health Serv Res 7 (2007) 64-76
42. Boter H., van Delden J.J.M., de Haan R.J., and Rinkel G.J.E. Patients' evaluation of informed consent to postponed information: cohort study. Br Med J 329 (2004) 86-87
43. Fleming M.F., Bruno M., Barry K., and Fost N. Informed consent, deception, and the use of disguised alcohol questionnaires. Am J Drug Alcohol Abuse 15 (1989) 309-319
44. Lustig B.A., Coverdale J., Bayer T., and Chiang E. Attitudes toward the use of deception in psychologically induced pain. IRB 15 (1993) 6 mv8
45. Shapiro A.K. Attitudes toward the use of placebos in treatment. J Nerv Ment Dis 130 (1960) 200-211
46. Hofling C.K. The place of placebos in medical practice. GP 11 (1955) 103-107
47. Salfield D.J. The placebo. Lancet 262 (1953) 940